Cargando…
GENESIS: a French national resource to study the missing heritability of breast cancer
BACKGROUND: Less than 20 % of familial breast cancer patients who undergo genetic testing for BRCA1 and BRCA2 carry a pathogenic mutation in one of these two genes. The GENESIS (GENE SISter) study was designed to identify new breast cancer susceptibility genes in women attending cancer genetics clin...
Ejemplares similares
-
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation
por: Ribeiro Guerra, Maximiliano, et al.
Publicado: (2021) -
Gene‐ and pathway‐level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility
por: Lonjou, Christine, et al.
Publicado: (2021) -
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing
por: Girard, Elodie, et al.
Publicado: (2018) -
GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers
por: Lesueur, Fabienne, et al.
Publicado: (2018) -
Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers
por: Renault, Anne-Laure, et al.
Publicado: (2018)